Study to support U.S. FDA approval of the Cordella™ Pulmonary Artery Pressure Sensor System for the treatment of patients with chronic heart failure LISLE, Ill., Feb. 18, 2020 /PRNewswire/ — Endotronix, a digital health and medical technology company dedicated to advancing the treatment of chronic heart failure (HF), today announced the enrollment of […]
Coronary/Structural Heart
Published Real-World Experience Demonstrates VasQ™ External Support Improves Outcomes When Adopted as the Standard of Care
TEL AVIV, Israel, Feb. 18, 2020 /PRNewswire/ — Dr. Robert Shahverdyan, Head of Vascular Access Center at Asklepios Klinik Barmbek of Hamburg, Germany, has recently published a retrospective analysis of his first 32 consecutive radiocephalic (forearm) VasQ™ External Support procedures in the Journal of Vascular Access. VasQ™ External Support, a Laminate Medical technology, is implanted […]
First patient enrolled in the new clinical study FILTER-SCAD targeting 2,000 patients
Press release Malmö, Sweden February 18, 2020 First patient enrolled in the new clinical study FILTER-SCAD targeting 2,000 patients Acarix AB (publ) today announced the initiation of the randomized, multi-center clinical study FILTER-SCAD to examine the cost effectiveness and safety of adding the CADScor®System as a rule-out test in patients referred with symptoms […]
BioVentrix Announces Gregg Stone, MD, as Co-Principal Investigator for ALIVE Pivotal Trial of Transcatheter Device for Heart Failure
SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., a pioneer of technologies and procedures for the less invasive treatment of heart failure (HF), today announced that Gregg Stone, MD, of New York’s Mount Sinai Health System has signed on to the pivotal ALIVE Trial of the Revivent TC™ TransCatheter Ventricular Enhancement System as co-principal investigator. Dr. Stone […]
Northwell Receives State Approval to Open Four Cardiac Catheterization Labs
Lenox Health Greenwich Village, Mather and Plainview hospitals join Northern Westchester to offer critical new cardiac services NEW HYDE PARK, N.Y.–(BUSINESS WIRE)–Three Northwell Health facilities – Lenox Health Greenwich Village, Mather Hospital in Port Jefferson and Plainview Hospital – have received approval this month from the New York State Health and Health Planning Council to […]
Northwestern Medicine Bluhm Cardiovascular Institute Celebrates 15 Years of Breakthrough Medicine
Number one cardiology and heart surgery program in Illinois for more than a decade; only program in Illinois with top 10 national U.S. News & World Report ranking CHICAGO, Feb. 14, 2020 /PRNewswire/ — Illinois’ highest ranked cardiology and heart surgery program. Among the highest survival rates for heart failure and heart attack […]
CARMAT Confirms the Submission of a “forfait Innovation” Dossier in France and Its Eligibility With Observations Received From the French National Authority for Health (HAS)
PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (FR0010907956, ALCAR) (Paris:ALCAR), the designer and developer of the world’s most advanced total artificial heart (TAH), aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, announces that the French National Authority for Health (HAS) has deemed the CARMAT TAH eligible with […]
Neovasc Achieves Design Freeze for Transfemoral Trans-septal Tiara™ Mitral Valve System
VANCOUVER and MINNEAPOLIS, Feb. 12, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE —Neovasc Inc.. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today achievement of design […]
CARMELINA® subgroup analysis supports long-term cardiovascular and renal safety of linagliptin in older people with type 2 diabetes
Linagliptin did not increase the risk of adverse cardiovascular events, hospitalization for heart failure or adverse kidney events compared with placebo in older people with type 2 diabetes in a prespecified subgroup analysis of the CARMELINA® cardiovascular outcome trial1 In addition, linagliptin did not increase the risk of hypoglycemia compared with […]
Hoag Now Offers the Most Comprehensive Aortic Disease Center in Southern California
– Renowned Stanford University specialist joins Hoag to bring care for Marfan Syndrome and Related Conditions to the Jeffrey M. Carlton Heart & Vascular Institute – Hoag Presenting Sponsor of the Marfan Foundation Southern California Walk for Victory in February 2020 NEWPORT BEACH, Calif., Feb. 10, 2020 /PRNewswire/ — Hoag’s Jeffrey M. […]



